Medicines in the EU that require special monitoring must now carry an inverted black triangle and accompanying warning label. The triangle does not indicate that the drug is unsafe, but rather that it requires careful oversight because it contains a new active ingredient or is subject to further studies. The triangle reminds health professionals and patients to report any suspected adverse effects from the medication.

Full Story:
PMLive.com (U.K.)

Related Summaries